CDK1 and neoplasm: Consistent with a proposed switch in the AR driven transcriptional program with local tumour progression, we observed a consistent increase in the expression of a number of these genes in higher-grade tumours, particularly CDK1, UBE2C, CDC20 and CCNA2 (Supplementary Figure S1).